Neuroprotection by acetoacetate and β-hydroxybutyrate against NMDA-induced RGC damage in rat-possible involvement of kynurenic acid

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 12, 2010, Pages 1729-1735

  Thaler, Sebastian ^a   Choragiewicz, Tomasz J ^a,b   Rejdak, Robert ^a,b,c   Fiedorowicz, Michal ^a,c   Turski, Waldemar A ^d   Tulidowicz Bielak, Maria ^b   Zrenner, Eberhart ^a   Schuettauf, Frank ^a   Zarnowski, Tomasz ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^d INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

hydroxybutyrate; Acetoacetate; Kynurenic acid; Neuroprotection; Retinal ganglion cells

Indexed keywords

3 HYDROXYBUTYRIC ACID; HYDROXYSTILBAMIDINE; KETONE BODY; KYNURENIC ACID; LITHIUM ACETOACETIC ACID; N METHYL DEXTRO ASPARTIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; DRUG DOSE COMPARISON; EXCITOTOXICITY; FEMALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA DEGENERATION; RETINA GANGLION CELL;

3-HYDROXYBUTYRIC ACID; ACETOACETATES; ANIMALS; CELL COUNT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAPERITONEAL; KYNURENIC ACID; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED BN; RETINAL GANGLION CELLS;

EID: 78549252390     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1425-7     Document Type: Article

References (42)

1. SR Sinha EH Kossoff 2005 The ketogenic diet Neurologist 11 161 170 10.1097/01.nrl.0000160818.58821.d2 15860138 (Pubitemid 40647238)
2. K Pierre L Pellerin 2005 Monocarboxylate transporters in the central nervous system: distribution, regulation and function J Neurochem 94 1 14 1:CAS:528:DC%2BD2MXlvFCksL4%3D 10.1111/j.1471-4159.2005.03168.x 15953344 (Pubitemid 40911387)
3. Y Kashiwaya T Takeshima N Mori K Nakashima K Clarke RL Veech 2000 D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease Proc Natl Acad Sci USA 97 5440 5444 1:CAS:528:DC%2BD3cXjsVWmsr8%3D 10.1073/pnas.97.10.5440 10805800 (Pubitemid 30313737)
4. L Massieu ML Haces T Montiel K Hernandez-Fonseca 2003 Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition Neuroscience 120 365 378 1:CAS:528:DC%2BD3sXlvVCltr8%3D 10.1016/S0306-4522(03)00266-5 12890508 (Pubitemid 37288773)
5. ML Prins SM Lee LS Fujima DA Hovda 2004 Increased cerebral uptake and oxidation of exogenous betaHB improves ATP following traumatic brain injury in adult rats J Neurochem 90 666 672 1:CAS:528:DC%2BD2cXmsFertrg%3D 10.1111/j.1471-4159.2004.02542.x 15255945 (Pubitemid 38989398)
6. M Suzuki M Suzuki K Sato S Dohi T Sato A Matsuura A Hiraide 2001 Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats Jpn J Pharmacol 87 143 150 1:CAS:528:DC%2BD3MXnvF2qu74%3D 10.1254/jjp.87.143 11700013 (Pubitemid 33039777)
7. R Masuda JW Monahan Y Kashiwaya 2005 D-beta-hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures J Neurosci Res 80 501 509 1:CAS:528:DC%2BD2MXktFemurg%3D 10.1002/jnr.20464 15825191 (Pubitemid 40780810)
8. BJ Dardzinski SL Smith J Towfighi GD Williams RC Vannucci MB Smith 2000 Increased plasma beta-hydroxybutyrate, preserved cerebral energy metabolism, and amelioration of brain damage during neonatal hypoxia ischemia with dexamethasone pretreatment Pediatr Res 48 248 255 1:CAS:528:DC%2BD3cXlvVyit78%3D 10.1203/00006450-200008000-00021 10926303
9. MR Hynd HL Scott PR Dodd 2004 Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease Neurochem Int 45 583 595 1:CAS:528:DC%2BD2cXlsVartr8%3D 10.1016/j.neuint.2004.03.007 15234100 (Pubitemid 38844879)
10. CJ Dong Y Guo P Agey L Wheeler WA Hare 2008 Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity Invest Ophthalmol Vis Sci 49 4515 4522 10.1167/iovs.08-2078 18566471
11. RJ Casson 2006 Possible role of excitotoxicity in the pathogenesis of glaucoma Clin Experiment Ophthalmol 34 54 63 10.1111/j.1442-9071.2006.01146.x 16451260 (Pubitemid 43379371)
12. SA Lipton 2007 Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation Curr Drug Targets 8 621 632 1:CAS:528:DC%2BD2sXlsVWmurc%3D 10.2174/138945007780618472 17504105 (Pubitemid 46785060)
13. M Seki SA Lipton 2008 Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma Prog Brain Res 173 495 510 1:CAS:528:DC%2BD1MXmtVamsg%3D%3D 10.1016/S0079-6123(08)01134-5 18929130
14. JT Coyle P Puttfarcken 1993 Oxidative stress, glutamate, and neurodegenerative disorders Science 262 689 695 1:CAS:528:DyaK2cXlvVek 10.1126/science.7901908 7901908
15. C Morizane K Adachi I Furutani Y Fujita A Akaike S Kashii Y Honda 1997 N(omega)-nitro-L-arginine methyl ester protects retinal neurons against N-methyl-D-aspartate-induced neurotoxicity in vivo Eur J Pharmacol 328 45 49 1:CAS:528:DyaK2sXjsVKgsbY%3D 10.1016/S0014-2999(97)83026-9 9203567 (Pubitemid 27241394)
16. HS Noh YS Hah R Nilufar J Han JH Bong SS Kang GJ Cho WS Choi 2006 Acetoacetate protects neuronal cells from oxidative glutamate toxicity J Neurosci Res 83 702 709 1:CAS:528:DC%2BD28Xislyitr8%3D 10.1002/jnr.20736 16435389 (Pubitemid 43384863)
17. M Gasior MA Rogawski AL Hartman 2006 Neuroprotective and disease-modifying effects of the ketogenic diet Behav Pharmacol 17 431 439 1:CAS:528:DC%2BD28XoslOnt7w%3D 10.1097/00008877-200609000-00009 16940764 (Pubitemid 44325805)
18. Z Zhao DJ Lange A Voustianiouk D MacGrogan L Ho J Suh N Humala M Thiyagarajan J Wang GM Pasinetti 2006 A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis BMC Neurosci 7 29 10.1186/1471-2202-7-29 16584562 (Pubitemid 44026744)
19. PS Hodgkins R Schwarcz 1998 Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate Eur J Neurosci 10 1986 1994 1:STN:280:DyaK1cvisVSjug%3D%3D 10.1046/j.1460-9568.1998.00208.x 9753086 (Pubitemid 28327347)
20. N Klöcker A Cellerino M Bähr 1998 Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells in vivo J Neuroscience 18 1038 1046
21. WA Turski M Nakamura WP Todd BK Carpenter WO Whetsell Jr R Schwarcz 1988 Identification and quantification of kynurenic acid in human brain tissue Brain Res 454 164 169 1:CAS:528:DyaL1cXks12ktrk%3D 10.1016/0006-8993(88)90815-3 3409000
22. T Zarnowski M Bialek R Rejdak E Zrenner A Junemann Z Zagorski T Kocki WA Turski 2006 Kynurenic acid synthesis in bovine retinal slices-effect of glutamate agonists J Neural Transm 113 1367 1372 1:CAS:528:DC%2BD28XpvVaqsLo%3D 10.1007/s00702-005-0423-0 16465462 (Pubitemid 44435874)
23. K Shibata 1988 Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography J Chromatogr 430 376 380 1:CAS:528:DyaL1cXls1eltr0%3D 10.1016/S0378-4347(00) 83173-4 3235510
24. R Siliprandi R Canella G Carmignoto N Schiavo A Zanellato R Zanoni G Vantini 1992 N-methyl-D-aspartate induced neurotoxicity in the adult rat retina Vis Neurosci 8 567 573 1:STN:280:DyaK383msFOjsQ%3D%3D 10.1017/S0952523800005666 1586655
25. N Kido H Tanihara M Honjo M Inatani T Tatsuno C Nakayama Y Honda 2000 Neuroprotective effects of brain-derived neurotrophic factor in eyes with NMDA-induced neuronal death Brain Res 884 59 67 1:CAS:528:DC%2BD3cXotVClurk%3D 10.1016/S0006-8993(00)02887-0 11082487
26. F Schuettauf D Zurakowski K Quinto MA Varde D Besch A Laties R Anderson R Wen 2005 Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells Graefes Arch Clin Exp Ophthalmol 243 1036 1042 1:CAS:528:DC%2BD2MXhtFart7bF 10.1007/s00417-005-1152-7 15838664 (Pubitemid 41631045)
27. F Schuettauf R Rejdak S Thaler S Bolz C Lehaci A Mankowska T Zarnowski A Junemann Z Zagorski E Zrenner P Grieb 2006 Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat Exp Eye Res 83 1128 1134 1:CAS:528:DC%2BD28XpvFGns7c%3D 10.1016/j.exer.2006.05.021 16876158 (Pubitemid 44397033)
28. L Massieu RP Del T Montiel 2001 Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates Neuroscience 106 669 677 1:CAS:528: DC%2BD3MXnslWntrg%3D 10.1016/S0306-4522(01)00323-2 11682154 (Pubitemid 33000173)
29. ML Haces K Hernandez-Fonseca ON Medina-Campos T Montiel J Pedraza-Chaverri L Massieu 2008 Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions Exp Neurol 211 85 96 1:CAS:528:DC%2BD1cXlsF2qtbc%3D 10.1016/j.expneurol.2007. 12.029 18339375
30. DC DeVivo MP Leckie JS Ferrendelli DB McDougal Jr 1978 Chronic ketosis and cerebral metabolism Ann Neurol 3 331 337 1:CAS:528:DyaE1cXksVSgt7s%3D 10.1002/ana.410030410 666275
31. K Tieu C Perier C Caspersen P Teismann DC Wu SD Yan A Naini M Vila V Jackson-Lewis R Ramasamy S Przedborski 2003 D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease J Clin Invest 112 892 901 1:CAS:528:DC%2BD3sXnsVGntL8%3D 12975474
32. KJ Bough J Wetherington B Hassel JF Pare JW Gawryluk JG Greene R Shaw Y Smith JD Geiger RJ Dingledine 2006 Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet Ann Neurol 60 223 235 1:CAS:528:DC%2BD28XovFyktL8%3D 10.1002/ana.20899 16807920 (Pubitemid 44182397)
33. J Mejia-Toiber T Montiel L Massieu 2006 D-beta-hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo Neurochem Res 31 1399 1408 1:CAS:528: DC%2BD28Xht1Oht77I 10.1007/s11064-006-9189-5 17115265 (Pubitemid 44900579)
34. LL Thio M Wong KA Yamada 2000 Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission Neurology 54 325 331 1:CAS:528:DC%2BD3cXhtV2ns7o%3D 10668691
35. SD Donevan HS White GD Anderson JM Rho 2003 Voltage-dependent block of N-methyl-D-aspartate receptors by the novel anticonvulsant dibenzylamine, a bioactive constituent of L-(+)-beta-hydroxybutyrate Epilepsia 44 1274 1279 1:CAS:528:DC%2BD3sXptVSks7k%3D 10.1046/j.1528-1157.2003.07203.x 14510820 (Pubitemid 37280371)
36. RL Veech B Chance Y Kashiwaya HA Lardy GF Cahill Jr 2001 Ketone bodies, potential therapeutic uses IUBMB Life 51 241 247 1:CAS:528:DC%2BD3MXmvF2mtrg%3D 10.1080/152165401753311780 11569918 (Pubitemid 32848155)
37. M Maalouf PG Sullivan L Davis DY Kim JM Rho 2007 Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation Neuroscience 145 256 264 1:CAS:528:DC%2BD2sXhvVGms7k%3D 10.1016/j.neuroscience.2006.11.065 17240074 (Pubitemid 46227735)
38. DR Ziegler LC Ribeiro M Hagenn IR Siqueira E Araujo IL Torres C Gottfried CA Netto CA Goncalves 2003 Ketogenic diet increases glutathione peroxidase activity in rat hippocampus Neurochem Res 28 1793 1797 1:CAS:528: DC%2BD3sXotFCmur4%3D 10.1023/A:1026107405399 14649719 (Pubitemid 37444674)
39. TK McIntosh KE Saatman R Raghupathi DI Graham DH Smith VM Lee JQ Trojanowski 1998 The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms Neuropathol Appl Neurobiol 24 251 267 1:CAS:528:DyaK1cXmtFKmt7o%3D 10.1046/j.1365-2990.1998.00121.x 9775390 (Pubitemid 28389121)
40. PS Hodgkins R Schwarcz 1998 Metabolic control of kynurenic acid formation in the rat brain Dev Neurosci 20 408 416 1:CAS:528:DyaK1cXntl2ltr0%3D 10.1159/000017338 9778579 (Pubitemid 28496971)
41. H Tsukada S Nishiyama D Fukumoto K Sato T Kakiuchi EF Domino 2005 Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys Neuropsychopharmacology 30 1861 1869 1:CAS:528:DC%2BD2MXhtVSls7nO 10.1038/sj.npp.1300732 15841110 (Pubitemid 41486411)
42. V Pernet P Bourgeois PA Di 2007 A role for polyamines in retinal ganglion cell excitotoxic death J Neurochem 103 1481 1490 1:CAS:528:DC%2BD2sXhtl2jurjF 10.1111/j.1471-4159.2007.04843.x 17714450 (Pubitemid 47631806)